Archives
U0126 and the Adaptive Logic of MEK Inhibition
2026-09-21
U0126 is more than a pathway inhibitor: it is a mechanistic probe for separating immediate MEK1/2-ERK suppression from the adaptive signaling that can undermine durable response. This perspective connects U0126 workflow design with resistance biology, translational biomarker strategy, and rigorous interpretation of cancer models.
GST-Mediated Lambda-Cyhalothrin Resistance in M. usitatus
2026-09-20
The reference study identifies MuGSTs1-mediated antioxidant defense as a major contributor to lambda-cyhalothrin resistance in Megalurothrips usitatus. By inhibiting GST activity with diethyl maleate, the researchers linked weakened redox protection to lower antioxidant capacity, enhanced apoptosis, and a marked increase in insecticide sensitivity.
Fluorescent RNA Probes for Plant Defense Biology
2026-09-19
A mechanistic analysis of how Tuta absoluta manipulates tomato redox defense, and how fluorescent RNA labeling can help translational researchers extend that biology into more informative assay strategies.
METTL14–SMN Arginine Methylation Controls m6A
2026-09-18
The reference study identifies SMN as an arginine methylation-dependent interaction partner of METTL14 and connects this regulatory axis to RNA m6A deposition, DNA repair, spinal muscular atrophy, and hematopoiesis. Its combined cellular and mouse-model evidence suggests that METTL14 methylation helps maintain context-specific m6A homeostasis, while also defining important limits on how directly the findings can be generalized to motor-neuron disease.
NOTCH3 R545C in CADASIL: Vascular-Neuronal Injury
2026-09-18
A 2026 Neurobiology of Disease study uses a CRISPR/Cas9 mouse model carrying the NOTCH3 p.R545C mutation to connect CADASIL-associated vascular pathology with cognitive and hippocampal dysfunction. Its integrated behavioral, vascular, neuronal, and transcriptomic analysis supports a model in which cerebrovascular injury co-occurs with blood-brain barrier disruption, neuroinflammation, and impaired synaptic plasticity.
Protein A/G Magnetic Beads for TPM3 IP
2026-09-17
Use Protein A/G Magnetic Beads to convert vascular signaling questions into controlled IP, co-IP, and PTM workflows. This guide connects the TPM3–HDAC3–Khib mechanism to practical antibody capture, low-background protein interaction analysis, and troubleshooting decisions.
Cl-Amidine PAD4 Workflows for Translational Research
2026-09-17
Cl-Amidine enables controlled PAD4 inhibition across enzyme, cellular, and inflammatory disease workflows. This guide connects quantitative assay design with cancer research, rheumatoid arthritis research, and a septic shock murine model while clearly separating established product evidence from exploratory applications inspired by recent mitophagy research.
Digoxin, HIF-1α, and Thyroid Eye Disease Fibrosis
2026-09-16
A 2026 Biochemical and Biophysical Research Communications study identifies HIF-1α as a mechanistic link between hypoxia, inflammation, fibrosis, STAT3 signaling, and GSDME-associated pyroptosis in thyroid eye disease. In primary orbital fibroblasts, Digoxin reduced these responses in a concentration-dependent manner, supporting further preclinical evaluation rather than establishing clinical efficacy.
PTX3–TLR4/NF-κB/FGF21 in Femoral Head Necrosis
2026-09-16
Li et al. identify a PTX3–TLR4/NF-κB/FGF21 signaling axis that limits glucocorticoid-induced osteonecrosis of the femoral head by preserving osteogenesis and reducing apoptosis. Their combination of patient and experimental models, genetic deficiency, pharmacological inhibition, and downstream ATF3 intervention provides a mechanistic framework for studying bone-cell injury and therapeutic response.
Deferasirox and Ferroptosis: Iron Biology in HCC
2026-09-15
Deferasirox is an oral iron chelator with potential value in ferroptosis research, but its effects must be separated from the METTL16-SENP3-LTF pathway described in hepatocellular carcinoma. This guide translates that study into practical assay decisions, controls, and translational limitations.
HyperFluor 488 Goat Anti-Mouse IgG in ATII Assays
2026-09-15
HyperFluor 488 Goat Anti-Mouse IgG converts mouse-primary immunodetection into a flexible fluorescence workflow for ATII-cell studies of DRP1, mitochondrial fragmentation, and glycolytic remodeling. This practical guide connects immunofluorescence, flow cytometry, western blotting, and fluorescent immunohistochemistry with assay-specific controls and troubleshooting.
Cefotaxime in AMR Assays and Infection Models
2026-09-14
Cefotaxime gives researchers a practical third-generation cephalosporin antibiotic for connecting cell-wall inhibition with beta-lactamase activity, resistance phenotypes, and plasmid mobility. This guide translates recent CREC transmission findings into reproducible workflows, comparative assays, and troubleshooting decisions for antimicrobial resistance research.
Sulfo-NHS-Biotin for CADASIL Surfaceomics
2026-09-14
Learn how Sulfo-NHS-Biotin can support mechanistically rigorous CADASIL surface-protein studies. This guide connects amine-reactive labeling chemistry with the NOTCH3 R545C model, assay controls, and disease-relevant interpretation.
Laminin (925-933) Workflow for ECM Assays
2026-09-13
Laminin (925-933) is a defined Laminin B1 chain peptide for separating receptor-dependent adhesion from chemotactic migration. This practical guide covers coating, gradient design, assay controls, troubleshooting, and a careful bridge to ex vivo neurodegeneration research.
Fluconazole: From Target Inhibition to Resistance
2026-09-12
Fluconazole is more than a routine azole comparator: it is a mechanistic probe for ergosterol disruption and resistance phenotyping. This article connects molecular action, assay design, and the delayed-treatment Candida auris evidence into a practical framework for selecting interpretable research endpoints.
724 records 6/49 page Previous Next First page 上5页 678910 下5页 Last page